Memorial Sloan – Kettering Cancer Center, 1275 York Ave. New York, NY 10021 United States Memorial Sloan – Kettering Cancer CenterTraditionally, physicians have relied on information provided by cancer patients during their office visits as the primary means to assess the patient’s symptoms and side effects more info . However, serious consequences if if important symptoms go unreported in these visits because they occur between appointments. – a new study by researchers at Memorial Sloan – Kettering Cancer Center , that itself most severely ill most severely ill cancer patients and be able to ‘self-report ‘symptoms over the Internet are delivered so that important data in real-time to their health care providers. – In December 2007 issue of the Journal of Clinical Oncology, the study suggests a new direction in cancer treatment. A web-basedto the authors can complement traditional office visit discussions with online patient self reporting clinicians to fill important gaps in knowledge and thus significantly improve patient safety and quality of care. Care care has become increasingly complex, which visits can be compressed to This makes it difficult for clinicians to each each patient’s symptoms in this short time frame, ‘said the study ‘s lead author, Ethan Basch, an oncologist at MSKCC. ‘Because cancer therapies can be very toxic, early detection of symptoms and timely treatment is vital. What is exciting to us is online self – reporting that in the study, doctors warn crucial symptoms in real time. ‘.

Has grown in recent years evidence shows superior results in the treatment of lung tumors with high doses of radiation delivered in three or four treatments. The results of the study on patients treated operated from these short courses survival rates and local control rates were similar to those demonstrated traditional surgery. As moves moves towards adoption of minimally invasive alternatives for the treatment of data, comparing the results of surgery less invasive treatment options such as radiosurgery, become extremely important. – We feel the time is right to explore less invasive alternatives for early stage lung cancer patients, said Jack Roth, Professor and Bud Johnson Clinical Distinguished Chair, Department of Thoraci high dose Radiation Oncology, co – investigators of the study.


At the 2008 ASH Annual Meeting of, Clara D. Bloomfield, of of Ohio State University Columbus, be used by Henry M. Stratton Medal should be presented honoring an individual which contribution to hematology universally recognized lasted for a period of are for several years. Bloomfield are for her on their remarkable accomplishments in the area hematologic malignancies , especially acute myelogenous leukemia, for more than thirty years. Dr Bloomfield did make an important contribution to understanding the biology these disorders and practical application biological information in diagnostics, classification, and determining a prognosis and select of the curative therapeutic approaches.

The American Society of Hematology is to the world’s largest specialist society involved on the causes and treatment of of blood disorders. Their mission is to help the understanding, diagnosis, treatment and prevention of disorders the blood, bone marrow, and the immunologic, hemostatic, in haematological and vasculature. By encouraging research, clinical care, education, training and representation of interests in hematology.